Hair Relaxer Settlement Calculator 2026: What Decides Claim Value

Evidence That Can Support a Hair Relaxer Claim

The distinctive difficulty in hair relaxer cases is proving exposure. There is no implant record and no prescription history, so use evidence has to be assembled deliberately — and early.

What the Two Large Cohort Studies Actually Found

Two large cohort studies sit underneath this entire litigation, and together they say something narrower and more useful than most pages on the subject suggest. The first is the National Institutes of Health Sister Study, published in the Journal of the National Cancer Institute on 17 October 2022, which followed 33,497 American women aged 35 to 74 for roughly eleven years and recorded 378 uterine cancers. Women who used chemical straighteners four or more times in the previous year had an estimated 4.05% risk of uterine cancer by age 70, against 1.64% for women who never used them. That is a little over double — and it is double a small number, which is why the study’s own lead author, Alexandra White, Ph.D., called the doubling “concerning” while adding that uterine cancer is relatively rare.

The second study speaks more directly to the women this litigation is mostly about, and it is the one usually left out. Boston University’s Black Women’s Health Study followed roughly 45,000 Black women for up to 22 years and reported in Environmental Research in October 2023 that postmenopausal women who used relaxers more than twice a year, or for longer than five years, had more than a 50% higher rate of uterine cancer than women who never used them or used them rarely. That finding matters because roughly 60% of the straightener users in the Sister Study were Black women, and because Black women typically begin using these products younger and continue for longer.

Neither study proves that hair relaxers cause uterine cancer, and both sets of authors say so directly. The Sister Study team did not collect brand or ingredient information, so the work cannot point at any particular product; they named parabens, bisphenol A, metals and formaldehyde as plausible candidates and said more research was needed to confirm the findings. An association measured across tens of thousands of women over two decades is evidence a court can weigh, not a verdict it must accept. That distinction is the entire substance of the pretrial fight in MDL 3060, and it is the reason no honest page — including this one — can publish a number that your claim is “worth”.

For a claimant, the practical consequence is that a file is built from records rather than from the headline risk figure. Between them, the two studies describe the exposure pattern the science actually examined: frequent use, sustained across years, followed by a diagnosis. A claim that can document that pattern — purchase or salon history, the pathology report, the date of diagnosis and the years of use before it — sits inside the evidence base the litigation is built on. A claim that cannot is leaning on the association alone. Every figure above is published here with the primary source attached so you can check it yourself, which is the standard we hold the rest of this page to as well.

Hair Relaxer Lawsuit Filing Deadlines

Limitation periods for hair relaxer claims vary by state and generally run from the date of diagnosis, or from the point at which the connection between the diagnosis and the product could reasonably have been discovered. Several states apply a discovery rule that materially extends the window.

These deadlines do not pause because the MDL has not reached trial. Waiting for settlement figures to be published is the most expensive mistake available in this litigation, because a claim that expires before it is filed is worth nothing however strong its facts.

The analysis is individual, and a claim that appears time-barred under a general personal-injury deadline may not be. It is worth having the question answered properly.

Hair Relaxer Settlement Calculator FAQ

Sources and Further Reading